A Study of ALS-008176 in Infants Hospitalized With RSV
Public ClinicalTrials.gov record NCT02202356. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Double-blind, Placebo-controlled, 2-Part Study of Orally Administered ALS-008176 to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Ascending Dosing and Multiple Ascending Dosing in Infants Hospitalized With Respiratory Syncytial Virus (RSV) Infection
Study identification
- NCT ID
- NCT02202356
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 1
- Lead sponsor
- Alios Biopharma Inc.
- Industry
- Enrollment
- 183 participants
Conditions and interventions
Conditions
Interventions
- ALS-008176 Drug
- Placebo Drug
Drug
Eligibility (public fields only)
- Age range
- Up to 12 Months
- Sex
- All
- Healthy volunteers
- Not listed
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jul 22, 2014
- Primary completion
- Feb 14, 2018
- Completion
- Feb 14, 2018
- Last update posted
- Feb 2, 2025
2014 – 2018
United States locations
- U.S. sites
- 17
- U.S. states
- 13
- U.S. cities
- 17
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Children's of Alabama | Birmingham | Alabama | 35233 | — |
| Arkansas Children's Hospital Research Institute | Little Rock | Arkansas | 72202 | — |
| Long Beach Memorial Medical Center/Miller Children's and Women's Hospital of Long Beach | Long Beach | California | 90806 | — |
| Children's Hospital of Orange County | Orange | California | 92868 | — |
| The University of California at San Diego | San Diego | California | 92093 | — |
| LSU Health Sciences Center | Shreveport | Louisiana | 71103 | — |
| Massachusetts General Hospital | Boston | Massachusetts | 02114 | — |
| The Children's Mercy | Kansas City | Missouri | 64108 | — |
| University of Rochester | Rochester | New York | 14611 | — |
| The University of North Carolina at Chapel Hill | Chapel Hill | North Carolina | 27599 | — |
| Duke University | Durham | North Carolina | 27708 | — |
| The Research Institute at Nationwide Children's Hospital | Columbus | Ohio | 43205 | — |
| Children's Hospital/University of Tennessee | Memphis | Tennessee | 38103 | — |
| UT Southwestern Medical Center | Dallas | Texas | 75390 | — |
| Texas Children's Hospital/Baylor College of Medicine | Houston | Texas | 77030 | — |
| The University of Utah | Salt Lake City | Utah | 84112 | — |
| Seattle Children's Hospital | Seattle | Washington | 98105 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 60 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02202356, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Feb 2, 2025 · Synced Apr 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02202356 live on ClinicalTrials.gov.